Thinly traded nano cap Adial Pharmaceuticals (ADIL +18.2%) is up on a healthy 30x surge in volume, about 1.3M shares, in reaction to its receipt of a Notice of Allowance from the USPTO for a method of use patent covering lead candidate AD04 for the treatment of alcoholism.
The patent covers a method of treating alcohol use disorder with AD04 in patients with a specific serotonin biomarker.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.